Skip to main content
. Author manuscript; available in PMC: 2021 May 14.
Published in final edited form as: J Med Chem. 2020 Apr 17;63(9):4528–4554. doi: 10.1021/acs.jmedchem.9b01573

Table 2.

Inhibition of rat and human nNOS compared to murine and human iNOS by selected compoundsa

Ki (μM) Selectivity
compd rnNOS hnNOS miNOS hiNOS rn/mi hn/hi
7 0.045 0.088 16.3 6.94 362 79
10 0.119 0.151 2.86 3.55 24 24
12 0.055 0.060 24.2 29.9 441 498
29 0.039 0.046 32.8 21.1 841 459
32 0.052 0.076 45.7 43.9 879 578
33 0.044 0.045 8.18 29.4 186 653
36 0.043 0.063 16.4 24.6 382 390
37 0.053 0.046 21.0 34.8 397 757
a

Compounds 7, 10, 12, 29, 32, 33, 36, and 37 were assayed for in vitro inhibition against purified human iNOS (hiNOS) using known literature methods, and Ki values were calculated directly from IC50 values using the Cheng–Prusoff equation. IC50 values are the average of at least two replicates from 6–9 data points; all experimental standard error values (for the LogIC50) are less than ± 0.10. Ki values for isoforms: rat nNOS (rnNOS), human nNOS (hnNOS), and murine iNOS (miNOS) were included for comparison. Selectivity values are ratios of respective Ki values.

HHS Vulnerability Disclosure